EP2694056
Læknandi meðhöndlun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
2.4.2012EP published:
16.10.2019EP application number:
12715421.9
EP translation filed:
18.12.2019Grant published:
15.1.2020EPO information:
European Patent Register
Max expiry date:
1.4.2032Expiry date:
1.4.2026Next due date:
30.4.2026
Title:
THERAPEUTIC TREATMENT
Timeline
Today
2.4.2012EP application
16.10.2019EP Publication
18.12.2019Translation submitted
15.1.2020Registration published
1.4.2026Expires
Owner
Name:
AstraZeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
DAVIES, Barry, RobertAddress:
Macclesfield, Cheshire SK10 4TG, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161470668 PDate:
1.4.2011Country:
US
Classification
Categories:
A61K 31/337, A61K 31/519, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 3.4.2020
Expires: 1.4.2021
Payer: Árnason Faktor ehf.
Number: 10
Paid: 10.3.2021
Expires: 1.4.2022
Payer: Árnason Faktor ehf.
Number: 11
Paid: 10.3.2022
Expires: 1.4.2023
Payer: Árnason Faktor ehf.
Number: 12
Paid: 8.3.2023
Expires: 1.4.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 7.3.2024
Expires: 1.4.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 2.4.2025
Expires: 1.4.2026
Payer: Árnason Faktor ehf.